Search Count: 5
 |
De Novo Design Apixaban-Binding Protein: Apx1049
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2025-01-15 Classification: DE NOVO PROTEIN Ligands: GG2 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-01-15
Ligands: GG2
 |
De Novo Design Apixaban-Binding Protein: Apx1049
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2024-12-25 Classification: DE NOVO PROTEIN Ligands: GG2 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2024-12-25
Ligands: GG2
 |
Crystal Structure Of Apixaban-Bound Racemic Able
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2024-05-29 Classification: DE NOVO PROTEIN Ligands: GG2 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2024-05-29
Ligands: GG2
 |
Crystal Structure Of Apixaban-Bound Able
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2020-08-26 Classification: DE NOVO PROTEIN Ligands: SO4, ACT, GG2 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2020-08-26
Ligands: SO4, ACT, GG2
 |
Factor Xa In Complex With The Inhibitor Apixaban (Bms-562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-Piperidinyl)Phenyl)-4,5,6,7-Tetrahydro-1H-Pyrazolo[3, 4-C]Pyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2007-10-16 Classification: HYDROLASE Ligands: CA, GG2 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2007-10-16
Ligands: CA, GG2